US 9522137
Methods for dosing an orally active 1,2,4-Oxadiazole for nonsense mutation suppression therapy
granted A61KA61K31/4245A61K47/02
Quick answer
US patent 9522137 (Methods for dosing an orally active 1,2,4-Oxadiazole for nonsense mutation suppression therapy) held by PTC THERAPEUTICS, INC. expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PTC THERAPEUTICS, INC.
- Grant date
- Tue Dec 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/4245, A61K47/02, A61K47/10, A61K47/12